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Total Synthesis and Structure Revision of Halioxepine
Caroline Poock[a] and Markus Kalesse*[a, b, c]
Abstract: The first total synthesis of halioxepine is accom-
plished using a 1,4-addition for constructing the quaterna-
ry center at C10 and a halo etherification for the genera-
tion of the tertiary ether at C7. The correct structure of
halioxepine was determined by assembling different enan-
tiomeric building blocks and by changing the relative con-
figuration between C10 and C15.
Halioxepine (1) is a new meroditerpene isolated from the Indo-
nesian sponge Haliclona sp. by Tanaka and co-workers in
2011.[1] It shows moderate cytotoxic and antioxidant activity
and the structure was determined to comprise a hydroqui-
none, a tetrahydrooxepine and a cyclohexene moiety. The
major challenge in the structure elucidation was the fact that
the hydroquinone-tetrahydrooxepine and the cyclohexene
spin systems were difficult to relate to each other. Consequent-
ly, there was some degree of uncertainty about the relative
configuration of both regions with respect to each other so
that two possible relative configurations were proposed:
1S*,2S*,7R*,10S*,15S* or 1S*,2S*,7R*,10R*,15R*. In 2018, the
group of Rodriguez[2] reported two additional halioxepins,
namely halioxepine B (2) and C (3) (Figure 1). In addition to
NMR-experiments, they used DFT calculations to determine the
stereochemical relationship of the two stereoclusters separated
by two methylene units (C8, C9). Their analysis suggested
1S*,2S*,7R*,10R*,15R* to be the relative configuration of haliox-
epine (1) (Figure 1). In addition, they confirmed for halioxepine
C (1) the absolute configuration at position C1 with the aid of
the Mosher[3] ester method.
In the course of our ongoing program of accessing natural
products through total synthesis,[4] we started the synthesis of
halioxepine with the aim of confirming its proposed structure
and to access this family of natural products for further biolog-
ical investigation. Retrosynthetically, the stereoselective addi-
tion of the hydroquinone moiety should take place in the end-
game of the synthesis and take advantage of the stereochemi-
cal controlling properties of the alpha chiral center. The tetra-
hydrooxepine ring should be constructed via an iodine-mediat-
ed ether formation which leads back to fragments 4 and 5.
Compound 5 in turn, which should allow access to both, the
syn- and anti-configured tetrahydrooxepine, can be assembled
from Weinreb amide 6 and iodide 7. Both fragments can be
obtained rapidly from simple starting materials 8, 9 and 10
(Scheme 1).
The synthesis of fragment 6 commenced with an enantiose-
lective 1,4-addition[5] followed by acylation and subsequent
methylation as reported by Herzon.[6] This sequence already
generated the two chiral centers of this fragment in very high
Figure 1. Proposed structures of the halioxepines. For halioxepine (1) and
halioxepine B (2) only the relative configuration was proposed.
Scheme 1. Retrosynthetic analysis of halioxepine.
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selectivities and 61 % yield over three steps. Addition of
methyl magnesium bromide and subsequent elimination using
pTsOH established the trisubstituted double bond between
C11 and C12. The ester was reduced to its corresponding alco-
hol using LiAlH4 and finally, IBX oxidation followed by HWE-ole-
fination introduced the two carbons which will separate the
two chiral clusters (Scheme 2).
The synthesis of eastern fragment 7 started with aldehyde
9[9] which was converted to its corresponding Z-vinyl iodide 16
using a Zhao-Stork olefination. Subsequent halide-metal ex-
change generated the nucleophile which was added to alde-
hyde 10[10] to generate a racemic mixture. Allylic alcohol 17
was oxidized using IBX and selectively reduced with
(+)-DIPCl[3] to obtain the required Z-configured allylic alcohol
in good yields and selectivities. TES protection and transforma-
tion of the PMB ether to its corresponding iodide completed
the synthesis of eastern fragment 7 (Scheme 3).
The fragment coupling started with the halide-metal ex-
change of iodide 7 and addition to Weinreb amide 6. The de-
sired a,b-unsaturated ketone 19 was formed in good yield
along with small amounts of undesired ketone 25. Optimiza-
tion of the reaction conditions partially led to suppression of
byproduct formation, but only with diminishing yield of 19. As
the byproduct could be removed during further steps, the con-
ditions shown were applied. For reduction of the a,b-unsatu-
rated ketone, different conditions were investigated (e.g. Stryk-
ers reagent,[11] Raney-Ni,[12] DiBAlH + HMPA + CuI + MeLi[13]) but
only the combination of Co(acac)2 and DiBAlH gave full conver-
sion.[14] Subsequent Wittig olefination and removal of the TES
protecting group provided the starting material for the tetra-
hydrooxepine cyclization. This was accomplished with I(2,4,6-
collidine)2PF6
[15] to provide a non-separable mixture of the syn-
and anti-isomers (syn :anti = 1.2:1). Removal of the terminal
iodide was achieved with „super hydride“ (LiEt3BH) and the pri-
mary TBS group was removed with TBAF, which made separa-
tion of both diastereomers possible. At this stage nOe-experi-
ments could unambiguously identify the syn-tetrahydrooxe-
pine which was part of the proposed structure. For the end-
game of the synthesis, an aldol-type addition of TBS hydroqui-
none 23 to aldehyde 24 was envisioned.[16] For this, alcohol
syn-22 was oxidized and treated with a magnesium salt de-
rived from deprotonation of mono-protected hydroquinone
23.[17] The addition proceeded with high selectivity for the ex-
pected syn-diol which is proposed to proceed via a chelation-
controlled transition state. Removal of the remaining TBS
group with the aid of TBAF led to target molecule 1
(Scheme 4). Unfortunately, the NMR spectra significantly deviat-
ed from the ones of the authentic material (see Figure 3 and
the Supporting Information).
Since the isolation papers covered in detail the relative ori-
entation of both stereoclusters to each other, we believed that
the differences in the NMR spectra were the result of the op-
posite relative orientation of both stereoclusters. As the config-
uration of the eastern hemisphere depends on the configura-
Scheme 2. Synthesis of western fragment 6 (o2s = over two steps).
Scheme 3. Synthesis of eastern fragment 7.
Scheme 4. Coupling of both hemispheres and endgame of the synthesis of
1 (o2s = over two steps).




tion at C2 we reoxidized intermediate (S)-20 and reduced[3] the
a,b-unsaturated ketone with (@)-DIPCl. With the so obtained
inversion at C2 the steps carried out for the former isomer
were repeated. Fortunately, the cyclization proceeds with
higher selectivities (syn :anti = 2.3:1) and the aldol-type addition
of hydroquinone gave again good yields and selectivities for
diol 28 (Scheme 5). TBAF-mediated removal of the TBS group
provided iso-halioxepine 29. However, even the NMR spectra
of this isomer did not match the ones of the authentic materi-
al. So the problems in the configurational assignment were ob-
viously not solved by changing the stereoclusters.
A closer look into NMR spectra of compounds with frag-
ments similar to the cyclohexene-fragment revealed, that there
is a significant difference in 1H- and 13C-shifts for different rela-
tive orientations of the methyl groups corresponding to C20
and C18 (compare Figure 2, top).[18] Comparing those shifts to
the ones of authentic halioxepine and the synthesized isomers
1 and 29 (Figure 2, bottom), we suggest a syn-relationship of
Me-20 and Me-18 for authentic halioxepine. Consequently, our
next target was the proposed structure but with an inverted
configuration at the quaternary carbon at C10.
The synthesis of the new western hemisphere (C7–C15) re-
quired a slightly altered route. Again, an asymmetric 1,4-addi-
tion was performed generating a 1.3:1 isomeric mixture of bis-
methylated compound 31.[5] However, the isomeric mixture
was inconsequential as subsequent enamine formation and
1,4-addition led to stereoselective formation of the quaternary
center.[19] The ester and the keto-carbonyl groups were re-
duced and the primary alcohol was TBDPS-protected.[20] Then,
the secondary alcohol was re-oxidized and methyl addition fol-
lowed by elimination generated the double bond in an endo-
and exo-mixture. This was isomerized to the desired endo-
olefin with rhodium(III)-chloride,[21] which also removed the sili-
con protecting group (Scheme 6).
Oxidation of the so generated primary alcohol set the stage
for coupling with eastern segment 7. As a byproduct alcohol
42 was formed, but it could be removed during further steps.
Alcohol 35 was then oxidized and transformed to its corre-
Scheme 5. Synthesis of iso-halioxepine 29 (o2s = over two steps).
Figure 2. Comparison of 1H- and 13C-NMR shifts for cyclohexene-parts similar
to those in halioxepine.
Scheme 6. Synthesis of altered western fragment 34, coupling with eastern
fragment 7 and synthesis of iso-halioxepine 41 (o2s = over two steps,
o3s = over three steps).




sponding exo-methylene derivative. At this stage, PPTS re-
moved selectively the TES group in the presence of the TBS
group. As in the synthesis of the previous isomers, treatment
with I(2,4,6-collidine)2PF6 induced the tetrahydrooxepine for-
mation in favor of the desired isomer with a 1.6:1-ratio. After
TBAF deprotection, both isomers could be separated and alco-
hol 39 was oxidized and transformed in the above mentioned
aldol-type addition of mono-protected hydroquinone 23. Final-
ly, TBAF-mediated removal of the remaining TBS group provid-
ed compound 41 which again did not exhibit matching NMR
spectra. However, analyzing the NMR signals derived from the
methyl groups at C17, C18 and C20 we could clearly see that
these are in better agreement with the ones of the authentic
material (Figure 3).
Nevertheless, it could still be that we had to switch the rela-
tive configuration of the two stereoclusters in relation to each
other. This we could achieve by oxidizing alcohol (S)-37 and
reducing the so obtained ketone with (@)-DIPCl. The desired
allylic alcohol (R)-37[3] was obtained in very good yield and se-
lectivity and the subsequent tetrahydrooxepine cyclization suc-
ceeded in 88 % yield. Removal of the iodide was achieved by
treatment with LiEt3BH (85 %). The final steps, namely the re-
moval of the TBS group, oxidation followed by aldol-type addi-
tion (configuration at C1 was confirmed via Mosher ester anal-
ysis ;[3] see Supporting Information) and final deprotection pro-
vided isomer 46 which NMR spectra were in very good accord-
ance with the ones of the authentic material (see Figure 3 and
Supporting Information). However, the optical rotation value
had the opposite sign as reported in the isolation papers. We
therefore had synthesized the enantiomer of halioxepine
(Scheme 7).
A comparison of the 1H-NMR spectra of the here described
synthetic compounds with the one obtained from the authen-
tic material is a clear indication of the refined configuration of
the halioxepines. Additionally, even if the stereoclusters are
separated they obviously influence the chemical shifts signifi-
cantly. It should be pointed out here that in retrospect the
analysis looks quite conclusive, however, things are not so ob-
vious if one does not have isomers for comparison.
In summary, we were able to complete the first total synthe-
sis of halioxepine and by doing so to revise its configuration at
C10. The synthesis takes advantage of an asymmetric 1,4-addi-
tion and stereoselective Michael addition to control the config-
uration at the quaternary center and the one at C15. The ste-
reocenters of the eastern stereocluster are consecutively de-
rived from a stereoselective DIPCl reduction of a prochiral
ketone. The iodonium-induced ether cyclization occurred in
modest selectivities of 1.6:1. However, both isomers could be
separated easily on the subsequent stage. The final aldol-type
addition of the mono-protected hydroquinone occurred with
high selectivities (>19:1). In the light of these findings, it
seems very likely that the configuration at C10 of halioxepine
C also needs some additional examination. Due to the different
carbon skeleton in halioxepine B, the situation is not as clear
cut as for halioxepine and halioxepine C. Our ongoing investi-
gation in this direction will be reported in due course.
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Figure 3. Comparison of the 1H-NMR shifts of the methyl groups of different
halioxepine isomers to the one from natural halioxepine.
Scheme 7. Endgame in the synthesis of ent-Halioxepine (46) (o2s = over two
steps).
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